期刊文献+

C3肾小球病临床表现和病理改变的异质性 被引量:1

Heterogeneity of the clinical manifestations and pathology features in C3 glomerulopathy
下载PDF
导出
摘要 C3肾小球病是由于补体旁路途径异常活化介导的疾病。由于致病机制的多样性和多重性,C3肾小球病的临床表现与病理改变具有异质性,临床可以表现为尿检异常、高血压、肉眼血尿、肾病综合征、肾炎综合征、肾功能不全等,病理改变可以表现为膜增生性肾小球肾炎、系膜增生、新月体形成、局灶节段性坏死、弥漫增生和渗出病变等,预后也不均一。本文对C3肾小球病的临床表现及病理特征进行综述。 C3 glomerulopathy is a kind of glomerular diseases mediated by abnormal activation of alternative complement pathway. As diversity and multiplicity of pathogenic mechanism, heterogeneity exists in the clinical manifestation and pathological features of C3 glomerulopathy. The clinical manifestation of the disease may be shown as abnormality in urine, hypertension, hematuria, nephrotic syndrome, nephritic syndrome, renal insufficiency, etc. Membranoproliferative glomerulonephritis, mesangial proliferation, crescent formation, focal segmental necrosis, diffuse hyperplasia and exudative lesions, etc may be found in renal biopsies. Also, the prognosis of C3 glomerulopathy is not uniform. The clinical manifestations and pathological features of C3 glomerulopathy were reviewed in the present paper.
作者 王金泉
出处 《解放军医学杂志》 CAS CSCD 北大核心 2014年第12期998-1003,共6页 Medical Journal of Chinese People's Liberation Army
关键词 C3肾小球病 临床表现 病理学 临床 C3 glomerulopathy clinical manifestation pathology, clinical
  • 相关文献

参考文献32

  • 1王金泉.C3肾小球病的致病机制和对策[J].解放军医学杂志,2014,39(11):918-923. 被引量:3
  • 2Servais A, Fremeaux-Bacchi V, Lequintrec M, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome[J].J Med Genet, 2007, 44(3): 193-199.
  • 3Sethi S, Fervenza FC. Membranoproliferative glomerulo- nephritis: pathogenetic heterogeneity and proposal for a new classification[J]. Semin Nephrol, 2011, 31 (3): 341-348.
  • 4D'Agati VD, Bomback AS. C3 glomerulopathy: what's in a name[J]? Kidney Int, 2012, 82(4): 379-381.
  • 5Gale DP, Pickering MC. Regulating complement in the kidney: insights from CFHRS nephropathy[J]. Dis Model Mech, 2011, 4(6): 721-726.
  • 6Servais A, Noel LH, Roumenina LT, et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies[J]. Kidney Int, 2012, 82 (4): 454-463.
  • 7Jokiranta TS, Solomon A, Pangburn MK, et al. Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H[J]. J Immunol, 1999, 163(8): 4590-4596.
  • 8Smith RJ, Harris CL, Pickering MC. Dense deposit disease[J]. Mol Immunol, 2011, 48(14): 1604-1610.
  • 9Wang JQ Tang Z, Liu CL, et al. Clinical and pathological features of dense deposit disease in Chinese patients[J]. Clin Nephrol, 2012, 78(3): 207-218.
  • 10Lu DF, Moon M, Lanning LD, et al. Clinical features and outcomes of 98 children and adults with dense deposit disease[J]. Pediatr Nephrol, 2012, 27(5): 773-781.

二级参考文献60

  • 1Servais A, Freemeaux-Bacchi V, Lequintrec M, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet,2007,44(3 ) :193 -199.
  • 2Fakhouri F, Fremeaux-Bacchi V, Noel LH, et al. C3 glomerulopathy : a new classification. Nat Rev Nephrol, 2010,6 ( 8 ) :494 - 499.
  • 3Picketing MC, Cook HT. Translational mini-review series on complement factor H:renal diseases associated with complement factor H:novel insights from humans and animals. Clin Exp Immuno1,2008, 151 (2) :210 -230.
  • 4Rose KL,Paixao-Cavalcante D, Fish J, et al. Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest, 2008,118 ( 2 ) :608 - 618.
  • 5Welch TR. The complement system in renal diseases. Nephron,2001, 88(3) :199 -204.
  • 6Appel GB, Cook HT, Hageman G, et al. Membranoproliferative glomerulonephritis type II ( dense deposit disease) : an update. J Am Soc Nephro1,2005,16 (5) : 1392 - 1403.
  • 7Pickering M, Cook HT. Complement and glomerular disease: new insights. Curr Opin Nephrol Hypertens,2011,20 ( 3 ) : 271 - 277.
  • 8Walker PD, Ferrario F, Joh K, et al. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol, 2007,20 ( 6 ) : 605 -616.
  • 9Smith R J, Alexander J, Barlow PN, et al. New approaches to the treatment of dense deposit disease. J Am Soc Nephro1,2007,18 (9) : 2447 - 2456.
  • 10甄军晖,孙海平.膜增生.肾性肾小球肾炎和致密物沉积病//黎磊石,刘志红.中国肾脏病学.北京:人民军医出版社,2008:402-421.

共引文献18

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部